Also from this source

You just read:

CellSight Technologies Announces Strategic Collaboration With Boehringer Ingelheim to Develop a New Technology for Monitoring Anti-tumor T-Cell Activation

News provided by

CellSight Technologies

Nov 08, 2017, 07:40 EST